Montreux Equity Partners
   
 

Latest News

July 26, 2010
Moksha8 awarded Frost & Sullivan award for Excellence in Market Penetration - Latin America

April 30, 2010
NeurogesX Enters $40 Million Royalty Financing Agreement with Cowen Healthcare Royalty Partners

April 27, 2010
Asthmatx Receives FDA Approval for the Alair® Bronchial Thermoplasty System

March 18, 2010
Somaxon Announces FDA Approval of Silenor® (doxepin) for the Treatment of Insomnia



Action. Experience. Collaboration.

Montreux Equity Partners is a life sciences venture capital firm focused on building great pharmaceutical and medical device companies. Montreux's goal is to generate significant returns by investing in superior businesses with high quality management teams.

Montreux seeks investment opportunities in which it can add value beyond the commitment of capital. Montreux works with entrepreneurs and management teams who wish to operate in a dynamic partnership based on shared interests and common goals. Montreux's operating philosophy is anchored in a foundation of honesty, integrity, and uncompromising professionalism.

NVCA Member

©2010 Montreux Equity Partners. All Rights Reserved.